Graffi Shmuel, Leon Pia, Nahum Yoav, Gutfreund Shay, Spena Rossella, Mattioli Leila, Busin Massimo
Department of Ophthalmology, Villa Igea Hospital, Forlì, Italy.
Istituto internazionale per la Ricerca e Formazione in Oftalmologia, Forlì, Italy.
Br J Ophthalmol. 2018 May 29. doi: 10.1136/bjophthalmol-2017-311834.
To evaluate the outcomes of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) performed in eyes after failure of primary Descemet membrane endothelial keratoplasty (DMEK).
This was a retrospective, non-comparative interventional case series done in a tertiary care hospital. The study group included 21 eyes of patients which underwent UT-DSAEK following the failure of primary DMEK. Outcome measures included best spectacle-corrected visual acuity (BSCVA) and endothelial cell density (ECD) both recorded 6 and 12 months postoperatively as well as central graft thickness (CGT) measured 6 months after UT-DSAEK.
When considering only eyes without comorbidities (17 of 21), 12 months after UT-DSAEK, BSCVA was ≥20/25 in 12/13 (92%) eyes and ≥20/20 in 4/13 (30%) eyes. Mean ECD loss rate was 38.9% at 12 months postoperatively (range 8%-57%). Six months postoperatively, CGT averaged at 81±34 µm (range 34-131 µm). No intraoperative complications were recorded. Postoperatively, one patient (no. 8) had graft wrinkles that were fixed 2 days following UT-DSAEK. Four patients have developed intraocular lens (IOL) opacification, and two of them underwent IOL exchange. No other postoperative complications were recorded.
UT-DSAEK is instrumental in the management of primary DMEK graft failure, allowing visual rehabilitation which is comparable with that of repeat DMEK.
评估在初次Descemet膜内皮角膜移植术(DMEK)失败后的眼中进行超薄Descemet膜剥离自动内皮角膜移植术(UT-DSAEK)的效果。
这是一项在三级护理医院进行的回顾性、非对照性介入病例系列研究。研究组包括21例患者的21只眼,这些患者在初次DMEK失败后接受了UT-DSAEK。观察指标包括术后6个月和12个月记录的最佳眼镜矫正视力(BSCVA)和内皮细胞密度(ECD),以及UT-DSAEK术后6个月测量的中央移植物厚度(CGT)。
仅考虑无合并症的眼(21只眼中的17只),UT-DSAEK术后12个月,13只眼中有12只(92%)的BSCVA≥20/25,4只(30%)≥20/20。术后12个月平均ECD损失率为38.9%(范围8%-57%)。术后6个月,CGT平均为81±34 µm(范围34-131 µm)。未记录术中并发症。术后,1例患者(第8例)出现移植物皱褶,在UT-DSAEK后2天得到矫正。4例患者发生人工晶状体(IOL)混浊,其中2例接受了IOL置换。未记录其他术后并发症。
UT-DSAEK有助于处理初次DMEK移植物失败,可实现与重复DMEK相当的视力恢复。